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Simultaneous Endo-Epicardial Mapping of 
the Human Right Atrium: Unraveling Atrial 
Excitation
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Yannick J. H. J. Taverne, MD, PhD; Maarten C. Roos-Serote, PhD; Annejet Heida, MD; Frans B. S. Oei, MD, PhD; 
Ad J. J. C. Bogers , MD, PhD; Natasja M. S. de Groot , MD, PhD
BACKGROUND: The significance of endo-epicardial asynchrony (EEA) and atrial conduction block (CB), which play an important 
role in the pathophysiology of atrial fibrillation (AF) during sinus rhythm is poorly understood. The aim of our study was there-
fore to examine 3-dimensional activation of the human right atrium (RA).
METHODS AND RESULTS: Eighty patients (79% men, 39% history of AF) underwent simultaneous endo-epicardial sinus rhythm 
mapping of the inferior, middle and superior RA. Areas of CB were defined as conduction delays of ≥12 ms, EEA as activation 
time differences of opposite electrodes of ≥15 ms and transmural CB as CB at similar endo-epicardial sites. CB was more 
pronounced at the endocardium (all locations P<0.025). Amount, extensiveness and severity of CB was higher at the superior 
RA. Transmural CB at the inferior RA was associated with a higher incidence of post-operative AF (P=0.03). EEA occurred 
up to 84 ms and was more pronounced at the superior RA (superior: 27 ms [interquartile range, 18.3–39.3], versus mid-RA: 
20.3 ms [interquartile range, 0–29.9], and inferior RA: 0 ms [interquartile range, 0–21], P<0.001). Hypertension (P=0.009), dia-
betes mellitus (P=0.018), and hypercholesterolemia (P=0.015) were associated with a higher degree of EEA. CB (P=0.007) and 
EEA (P=0.037) were more pronounced in patients with a history of persistent AF compared with patients without AF history.
CONCLUSIONS: This study provides important insights into complex atrial endo-epicardial excitation. Significant differences in 
conduction disorders between the endo- and epicardium and a significant degree of EEA are already present during sinus 
rhythm and are more pronounced in patients with cardiovascular risk factors or a history of persistent AF.
Key Words: atrial fibrillation ■ cardiac mapping ■ electropathology ■ electrophysiology
Mapping of atrial excitation is usually performed at either the endo- or epicardium, assuming that electrical conduction in the 2-dimensional plane 
is representative of transmural excitation. However, 
prior mapping studies demonstrated that the endo- 
and epicardial layers are excited asynchronously not 
only during atrial fibrillation (AF) but also during sinus 
rhythm (SR).1–4 This endo-epicardial asynchrony (EEA) 
favors transmural propagation of fibrillation waves re-
sulting in so-called focal waves in the opposite layer, 
thereby perpetuating the fibrillatory process. A certain 
degree of EEA is a requisite for the occurrence of 
transmural conduction and is promoted by difference 
in conduction disorders between the endo- and epi-
cardial plane.
Previous studies have demonstrated that con-
duction disorders, mainly longitudinal dissociation 
in conduction, are associated with genesis and per-
petuation of atrial tachyarrhythmias such as AF.5,6 
Several mapping studies demonstrated that conduc-
tion disorders in the epicardial plane play a key role 
in the pathophysiology of AF.6–10 It is most likely that 
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when conduction disorders occur in either the 2-di-
mensional endo- or epicardial plane, they also occur 
in the 3-dimensional plane, thus transmurally. The 
first step in understanding “3-dimensional” atrial ex-
citation is to investigate transmural conduction during 
SR. However, there are at present no techniques 
enabling direct assessment of transmural conduc-
tion disorders in the in vivo human heart. The aim of 
our study was therefore to investigate the correlation 
between features of conduction disorders assessed 
in the endo- and epicardial plane and the degree of 
EEA by conducting high-resolution simultaneous en-
do-epicardial mapping studies in patients undergoing 
cardiac surgery.
METHODS
The data that support the findings of the present study 
are available from the corresponding author on rea-
sonable request.
Study Population
The study population consisted of 80 patients un-
dergoing elective primary open heart surgery in the 
Erasmus Medical Center Rotterdam. Patients under-
went either coronary artery bypass surgery, valve sur-
gery or a combination of both. If indicated, patients 
with a history of AF underwent concomitant AF ab-
lation. Patients with hemodynamic instability, atrial 
paced rhythm, previous open cardiac surgery, severe 
liver, or renal failure or severely impaired left ventricular 
function were excluded from the study. This study was 
approved by the institutional medical ethics committee 
(MEC2015-373), and written informed consent was ob-
tained from all patients. The study was performed ac-
cording to the principles of the Declaration of Helsinki. 
Patient characteristics were obtained from electronic 
medical files.
Simultaneous Endo-Epicardial Mapping 
of the Right Atrium
Trained and experienced cardiothoracic surgeons per-
formed simultaneous endo-epicardial high-resolution 
mapping before commencement to extra-corporal cir-
culation, as previously described in detail.11 Two elec-
trode arrays, each containing 128 electrodes with an 
electrode diameter of 0.45 and 2 mm inter-electrode 
spacing, were firmed on 2 bendable spatulas and 
positioned on the exact opposite side of each other. 
After heparinization and arterial cannulation, a tempo-
rary bipolar epicardial pacemaker wire was stitched to 
the free wall of the right atrium (RA) and served as a 
temporal reference electrode. The indifferent electrode 
was connected to a steel wire which was stitched to the 
subcutaneous tissue of the thoracic wall. Then a purse 
string suture was placed in the right atrial append-
age for venous cannulation. Before venous cannula-
tion, 1 spatula (marked as the endocardial electrode 
array) was introduced in the RA after incising the right 
atrial appendage and the incision site was closed with 
the purse string suture. Simultaneous endo-epicardial 
mapping was performed following a predefined map-
ping scheme with 3 different locations on the RA-free 
wall: (1) superior RA, (2) mid-RA, and (3) inferior RA, 
as depicted in Figure 1A. During the mapping proce-
dure, real-time electrograms were visualized on multi-
ple screens to enable intraoperative evaluation of the 
electrograms. Simultaneous endo-epicardial mapping 
was performed for 5 seconds during SR, and included 
a surface ECG lead, a calibration signal of 2 mV and 
CLINICAL PERSPECTIVE
What Is New?
• At present, this is the largest right atrial simul-
taneous endo-epicardial mapping study per-
formed in patients undergoing cardiac surgery.
• Significant differences in atrial conduction dis-
orders between the endo- and epicardium and 
a considerable degree of endo-epicardial asyn-
chrony are present during sinus rhythm.
• Interestingly, the presence of cardiovascular risk 
factors and a history of atrial fibrillation enhance 
electrical disturbances in the atria.
What Are the Clinical Implications?
• Our findings highlight the complex nature of 
atrial excitation.
• The present study demonstrates that endo-ep-
icardial asynchrony is most likely a physiologi-
cal phenomenon, which is aggravated by atrial 
fibrillation and the presence of cardiovascular 
risk factors.
• Endo-epicardial mapping provides mechanistic 
insights into atrial excitation during sinus rhythm 
and may be useful for guiding patient tailored 
therapy of atrial fibrillation.
Nonstandard Abbreviations and Acronyms
AF atrial fibrillation
CB conduction block
CD conduction delay
EEA endo-epicardial asynchrony
LA left atrium
RA right atrium
SR sinus rhythm
TAT total activation time
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1000 ms, a bipolar reference electrogram and all endo- 
and epicardial unipolar electrograms. Recordings were 
sampled with a rate of 1  kHz, amplified (gain 1000), 
filtered (bandwidth 0.5–400 Hz), analog-to-digital con-
verted (16-bits) and stored on a secured hard disk.
Mapping Data Analysis
Mapping data was analyzed using semi-automatized 
custom-made Python 3.6 software. Activation maps 
of both the epicardial and the endocardial layer were 
constructed by annotating the steepest negative 
slope of atrial potentials recorded at every electrode. 
Premature atrial complexes, electrograms with injury 
potentials, and recordings with ≥30% poor quality 
electrograms were excluded from analysis by consen-
sus of 2 investigators.
Endo-Epicardial Asynchrony
As demonstrated in Figure 1B and 1C, local endo-ep-
icardial activation time differences were determined by 
selecting the median of the time delays within the exact 
opposite electrode and its 8 surrounding electrodes 
resulting in an epicardial and endocardial asynchrony 
map. The combined asynchrony map shows the long-
est time delay for every endo-epicardial electrode pair. 
Consistent with prior mapping studies, EEA was defined 
Figure 1. Simultaneous endo-epicardial mapping of the right atrium.
A, Two spatulas with 128-electrode arrays (Ø electrode=0.4  mm, interelectrode distance=2  mm) are fixed together, 1 spatula is 
introduced into the right atrium through the incision for venous cannulation and one spatula is positioned on the opposite epicardial 
surface. Unipolar electrogram recordings are recorded at 3 mapping locations: (1) the superior caval vein (superior), (2) the inferior 
caval vein (inferior) and in between, (3) the terminal crest (mid). B, In the mapping clamp with endo- and epicardial electrode arrays, 
exact opposite electrodes are marked with yellow or red dots. The surrounding 8 electrodes are marked with black or blue squares. 
These electrodes are enlarged in C. C, The local activation times of direct opposite and its 8 surrounding electrodes are shown. 
Differences in local activation time between the reference electrode and the 9 opposite electrodes are calculated for the endo- and 
epicardium. Endo-epicardial asynchrony was defined as a median time delay ≥15 ms. D, The arrows in the activation maps of the 
epi- and endocardium indicate the main direction of the propagating wavefronts. The conduction map indicates lines of conduction 
block (CB) (>12 ms) marked by thick lines. Different areas of CB, depicted by thick black lines, are observed in both the epi- and 
endocardium at the same location (<2 mm), indicative of “transmural” CB.
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as transmural difference in electrical activation of ≥15 ms 
between every endo-epicardial electrode pair.3,4 Total 
amount of EEA during the entire recording period was 
calculated as a percentage of the total mapping area.
Total activation times (TAT), for both the endo- and the 
epicardium, were calculated by the differences in activa-
tion time between the first and latest activated electrode; 
only mapping recordings with ≥95% marking were in-
cluded for this specific analysis. All activation maps and 
calculations were manually checked by 2 investigators.
Conduction Disorders
Consistent with prior epicardial mapping studies, areas 
of conduction delay (CD) and conduction block (CB) 
were defined as interelectrode differences in local ac-
tivation times of, respectively, 7 to 11 ms and ≥12 ms 
corresponding with effective conduction velocities of 18 
to 28 cm/s for CD and <18 cm/s for CB.6 Areas of unin-
terrupted CD and CB lines were defined as continuous 
CDCB lines. In addition, the median and longest length 
of all CB and continuous CDCB lines were calculated 
for analyses. The amount of CB and continuous CDCB 
was calculated as a percentage of the total mapping 
area. Transmural CB was defined as lines of CB in both 
layers with a horizontal spatial difference of ≤2 mm. An 
example of transmural CB is depicted in Figure 1D.
Statistical Analysis
Normally distributed continuous variables were ex-
pressed as mean±SD and skewed variables as median 
with interquartile range (IQR). Categorical data were 
presented as numbers and percentages and com-
pared with the Chi-squared test. Wilcoxon signed-rank 
test or Kruskal–Wallis test was used to compare con-
tinuous parameters between the mapping locations. 
Friedman test was used to investigate the associations 
between mapping location (independent variable) and 
electrophysiological parameters (dependent variable). 
Comparison of conduction disorders in the endo- and 
epicardial was performed with the Wilcoxon signed 
rank test. Association of clinical characteristics and 
electrophysiological parameters were analyzed with 
the Wilcoxon rank sum test. Spearman rho coefficient 
was used to determine the correlation between con-
duction disorders and EEA. A P value of <0.05 was 
considered statistically significant. Statistical analyses 
were performed using IBM SPSS Statistics version 21 
(IBM Corp, Armonk, NY).
RESULTS
Study Population
Baseline characteristics of the 80 enrolled patients 
(79% men, aged 66±9 years) are summarized in Table. 
Patients were categorized by underlying heart disease; 
ischemic heart disease (n=38, 48%), valvular heart dis-
ease (n=23, 29%), or a combination of ischemic/valvu-
lar heart disease (n=18, 23%). One patient underwent 
lone surgical AF ablation. A total of 31 patients had a 
history of AF, including paroxysmal (n=25, 31%), persis-
tent (n=4, 5%), and longstanding persistent (n=2, 3%). 
Postoperative AF occurred in 30 patients (37.5%). Left 
atrial dilatation was present in 27 patients (34%) and 
the majority of the patients had normal left ventricular 
function (n=55, 69%).
Mapping Data
A total of 80 inferior, 80 mid-, and 73 superior RA re-
cordings including 337.094 atrial electrograms were 
Table. Patient Characteristics
No. of Patients 80
Age (y) 66.4±9.0 (range, 46.7–85.5)
Men 63 (78.8)
BMI (kg/m2) 28.2±4.5 (range, 17.4–39.5)
Underlying heart disease n (%)
IHD 38 (47.5)
VHD 23 (28.8)
I/VHD 18 (22.5)
Valvular heart disease 37 (46)
MVD 25 (31.3)
AVD 20 (25.0)
TVD 5 (6.3)
History of AF 31 (38.8)
Paroxysmal 25 (31.3)
Persistent 4 (5.0)
Longstanding persistent 2 (2.5)
Cardiovascular risk factors
Hypertension 51 (63.8)
Hypercholesterolemia 41 (51.3)
Diabetes mellitus 27 (33.8)
Left ventricular function
Normal 55 (68.8)
Mild dysfunction 13 (16.3)
Moderate dysfunction 11 (13.8)
Severe dysfunction 1 (1.3)
Right atrial dilatation 5 (6.3)
Antiarrhythmic drugs 65 (81.3)
Class I 2 (2.5)
Class II 56 (70.0)
Class III 6 (7.5)
Class IV 7 (8.8)
Digoxin 8 (10)
AF indicates atrial fibrillation; AVD, aortic valve disease; BMI, body mass 
index; I/VHD, ischemic and valvular heart disease; IHD, ischemic heart 
disease; MVD, mitral valve disease; TVD, tricuspid valve disease; and VHD, 
valvular heart disease.
D
ow
nloaded from
 http://ahajournals.org by on September 18, 2020
J Am Heart Assoc. 2020;9:e017069. DOI: 10.1161/JAHA.120.017069 5
Kharbanda et al. Simultaneous Endo-Epi Mapping of the Right Atrium
of adequate quality for analysis. This yielded in 1395 
SR activation maps with a median SR cycle length of 
888 ms (IQR, 756–1016) which did not differ between 
the various mapping locations (all P>0.61). Only for TAT 
analysis, 74 mapping locations (32%) were excluded as 
<95% of the mapping area was activated.
Differences in Prevalence of Endo- and 
Epicardial Conduction Disorders
There was no difference in TAT of opposite endocar-
dial and epicardial mapping locations (endocardium: 
32 ms [IQR, 25–40], epicardium: 32 ms [IQR, 26–39], all 
P>0.609). However, TAT at both the endo- and epicar-
dium separately was longest at superior RA (endocardium 
TAT: inferior: 30.5 ms [IQR, 25–38.6] mid-: 30 ms [IQR, 
24–37.8], superior: 37 ms [IQR, 28–44.5] P=0.006, epicar-
dium TAT: inferior: 30 ms [IQR, 25.4–35] mid-: 31 ms [IQR, 
24–40.8] superior: 37 ms [IQR, 31–41], P<0.001).
Figure  2 illustrates the amount of CB (in percent-
age of the mapping area) for all endo- and epicardial 
mapping locations separately; locations are ranked 
according to amount of CB in each layer. At the epi-
cardium, the prevalence of CB ranged from 0% to 
19.2% (median, 1.1%) and 24.1% of the locations did 
not contain any lines of CB. At the endocardium, the 
prevalence of CB ranged from 0% to 21.6% (median, 
1.9%) and lines of CB were absent at only 17.2% of the 
locations. The prevalence of continuous CDCB for the 
epi- and endocardium was, respectively, 1.8% [IQR, 
0–5.5] and 3.05% [IQR, 0.4–7.2].
The table in Figure  2 demonstrates the amount 
of CB in the endo- and epicardial plane for the 3 
different mapping locations separately. At every lo-
cation, the amount of CB was highest at the endo-
cardium compared with the epicardium (all P<0.025). 
Comparing the 3 different locations, the highest 
amount of CB (4.4% [IQR, 1.5%–8.9%]) occurred at 
the superior RA endocardium. Similar findings were 
observed for continuous CDCB; CB was most often 
observed at the RA superior endocardium (5.2% 
[IQR, 2%–11.9%], P=0.027). The activation maps of 
the endo- and epicardium, which are depicted on the 
left and middle panel of Figure 3, clearly demonstrate 
differences in CB (thick black lines) between adja-
cent layers.
The total amount of conduction disorders at both 
the endo-epicardium combined was higher at the 
superior RA in patients with hypertension compared 
with patients without hypertension (CB; P=0.046, 
4.3% [IQR, 1.9%–8.5%] versus 2.9% [IQR, 1%–5.2%], 
CDCB; P=0.027, 6.4% [IQR, 2.5%–10.6%] versus 3% 
[IQR, 1.4%–5.7%].
Differences in Extensiveness of Endo- 
and Epicardial Conduction Disorders
Examples of color-coded activation maps shown in 
Figure 3 demonstrate that areas of CB and continu-
ous CDCB may vary from short scattered short lines 
to long continuous lines. Length of CB and continu-
ous CDCB lines at the epicardium were, respectively, 
3 mm (IQR, 2–6) and 8 mm (IQR, 0–14) whereas at 
the endocardium, lines of CB and continuous CDCB 
were, respectively, 4  mm (IQR, 2–6) and 10  mm 
(IQR, 6–15). Comparing the endo- and epicardium, 
lengths of both CB and continuous CBCD lines were 
solely significantly longer at the inferior RA endocar-
dium (CB, 3 mm [IQR, 0–5] versus 2 mm [IQR, 0–4], 
P=0.013; CDCB 8 mm [IQR, 0–13.75] versus 5.5 mm 
[IQR, 0–10], P=0.007). In patients with hyperten-
sion, the length of all endo- and epicardial CB lines 
were again longer at both the superior (P=0.018, 
5 mm [IQR, 4–7] versus 4 mm [IQR, 2–6]) and inferior 
(P=0.036, 4 mm [IQR, 2–6] versus 2 mm [IQR, 0–3.5]) 
location. However, lengths of continuous CDCB lines 
were longer in patients with hypertension at only the 
Figure 2. Spatial distribution of atrial conduction disorders.
Upper panel: Amount of CB for all endo- and epicardial mapping 
locations separately. The highest amount of CB at the endo- and 
epicardium was, respectively, 21.6% and 19.2%. No CB in either 
the endo- or epicardium occurred in, respectively, 17.2% and 
24.1% of all patients. Lower panel: Amount of CB in the endo- 
and epicardial plane for each mapping location separately. The 
endocardium had significant more CB at each mapping location. 
CB indicates conduction block; and IQR, interquartile range.
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superior RA (P=0.023, 14  mm [IQR, 10–18] versus 
10 mm [IQR, 8–14.3]). Patients with hypercholester-
olemia (P=0.013, 4 mm [IQR, 2–6] versus 2 mm [IQR, 
0–4]) or diabetes mellitus (P=0.025, 4 mm [IQR, 2–6] 
versus 2 mm [IQR, 1.5–4]) also had significant longer 
CB lines at the inferior RA.
Severity of Conduction Block in the  
Endo- and Epicardium
The upper panel of Figure 4 demonstrates all conduc-
tion times (n=598 808) measured between neighboring 
electrodes of the 3 different endo- and epicardial map-
ping locations combined. Of all CTs, 3% was ≥12 ms 
indicating CB.
The lower panel of Figure  4 shows the maximal 
conduction times obtained from every patient at each 
of the 3 mapping locations separately. The severity of 
CB was highest at the superior RA (P<0.001, inferior: 
17 ms [IQR, 13–25], mid-: 22 ms [IQR, 15–33.8], supe-
rior: 28 ms [IQR, 21–40.5]). However, in patients with 
hypertension and hypercholesterolemia, most severe 
CB occurred at the inferior RA (respectively, P=0.037 
at 20 mm [IQR, 14–27] versus 15 mm [IQR, 11–23], and 
P=0.010 at 20 mm [IQR, 14.5–27] versus 15 mm [IQR, 
11–22]).
Transmural Conduction Block
The right panel of Figure  3 shows color-coded acti-
vation maps of both the endo-and epicardium. The 
distal part of the mapping arrays (distal in regard to 
the incision) clearly demonstrates an oblique line of 
CB which can be observed at both the endo- and 
epicardium and is therefore most likely transmurally 
present. Transmural CB depicted at the proximal part 
of the mapping arrays is also present in both layers, 
however the area of CB is more extensive at the endo-
cardium. The incidence of this so-called transmural CB 
also increased from inferior to superior RA (inferior RA, 
26.3%; mid-RA, 39.2%; and superior RA, 57.5% of the 
patients, P<0.001). Transmural CB at the inferior, rela-
tive thin, RA appeared to be associated with a higher 
risk of postoperative AF (P=0.03).
Figure 3. Endo-epicardial activation patterns.
Examples of color coded activation maps demonstrating differences in activation between the endo- and epicardium including differences 
in local electrograms. The arrows display that the main wave trajectories and local activation times are depicted near the head and tail. 
Thick black lines indicate lines of conduction block. The endo-epicardial asynchrony map (delay ≥15 ms), shows the time delay assessed 
at every coupled recording site. CB indicates conduction block; EEA, endo-epicardial asynchrony; and SR, sinus rhythm.
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Endo-Epicardial Asynchrony
The middle panel of Figure 3 shows an example of color-
coded activation maps of adjacent endo- and epicardial 
layers. Both layers were activated within 52 ms and in the 
middle of the mapping area, a long line of CB (thick black 
line) can only be observed at the endocardium. The cor-
responding EEA map shows that EEA is highly prevalent 
in the upper part of the mapping area during SR and 
occurred up to 44 ms in this patient. Electrograms re-
corded from 2 opposite electrodes clearly demonstrate 
the differences in local activation times (32 ms).
The prevalence of EEA measured at the 3 different 
mapping locations together is shown in Figure 5. Of all 
mapping locations, EEA was observed in 67.4%. EEA 
was absent in 52.5%, 33.8%, and 15.1% of, respec-
tively, the inferior, mid-, and superior location. Hence, 
the prevalence of EEA was highest at the superior RA 
(84.9% of the patients, P<0.001). The median delay, in-
dicating the degree of EEA, between both layers was 
highest at the superior RA (superior: 17.5  ms [IQR, 
16–21.75] versus mid-: 17 ms [IQR, 0–20], and inferior: 
0 ms [IQR, 0–17], P<0.001). The largest delay in acti-
vation time between the endo- and epicardium was 
also highest at the superior RA (superior: 27 ms [IQR, 
18.3–39.3] versus mid-: 20.3 ms [IQR, 0–29.9] and in-
ferior: 0 ms [IQR, 0–21], P<0.001).
The left panel of Figure 5 shows the relative distri-
bution of all endo-epicardial delay times (n=161 650) 
in the entire study population, ranked according to 
the degree of endo-epicardial delay. The far majority 
of all measurements, namely 95% of all endo-epicar-
dial delay times (n=153 568), was below the EEA cut-
off value of 15 ms. However, the maximal degree of 
EEA measured during SR at the inferior, mid-, and 
superior RA ranged from 61 ms at the inferior RA up 
to 84 ms at the superior RA. Patients with hyperten-
sion (P=0.009, 0.3% [IQR, 0%–3.4%] versus 0% [IQR, 
0%–0.4%]), diabetes mellitus (P=0.018, 1% [IQR, 0%–
4.8%] versus 0% [IQR, 0%–1%]) and hypercholester-
olemia (P=0.015, 0.7% [IQR, 0%–3.4%] versus 0% 
[IQR, 0%–0.5%]) had a significantly higher degree of 
EEA at the inferior mapping location compared with 
patients without these cardiovascular risk factors.
Both the incidence (inferior RA, r=0.78; mid-RA, 
r=0.84; and superior RA, r=0.87, all P<0.001) and se-
verity (inferior RA, r=0.69; mid-RA; r=0.83; and supe-
rior RA, r=0.82, all P<0.001) of CB in the endo- and 
epicardium together correlated with the incidence of 
EEA at every location.
Influence of AF history on conduction 
disorders and EEA
Comparing endo-epicardial conduction disorders as 
described above during SR between patients with no 
AF history (n=49), paroxysmal AF (n=25) and (longstand-
ing) persistent AF (n=6) resulted in differences solely 
observed at the inferior RA mapping location. Patients 
with (longstanding) persistent AF showed more endo-
epicardial CB (median, 3.9% [IQR, 1.9%–5.9%] versus 
0.8% [IQR, 0.2%–2.0%], P=0.007), continuous CDCB 
(median, 6.5% [IQR, 3.7%–11.5%] versus 1.0% [IQR, 
0.2%–3.5%], P=0.001) and incidence of EEA (median, 
2.5% [IQR, 0.5%–6.2%] versus 0% [IQR, 0%–1.2%], 
P=0.037) compared with patients with no history of AF. 
In addition, median and longest length of continuous 
CDCB lines in the inferior RA were also longer in these 
patients (median length, 15.5 mm [IQR, 11.5–20.25] ver-
sus 8 mm [IQR, 0–12], P=0.005; longest length, 28 mm 
[IQR, 21–54.5] versus 12 mm [IQR, 6–22] P=0.004).
DISCUSSION
Key Findings
High resolution simultaneous endo-epicardial SR 
mapping of the RA in patients with structural heart 
disease revealed that conduction disorders were 
Figure 4. Characteristics of atrial conduction disorders.
Upper panel: Distribution of all conduction times measured at 
the 3 mapping locations. Of all 598.808 conduction times, only 
3% (n=17.965) was ≥12 ms (cut-off value for CB). The maximal 
conduction time between 2 neighboring electrodes measured in 
our population was 86 ms. Lower panel: Distribution of maximal 
conduction times, indicating the severity of conduction block, for 
each mapping location separately. Conduction block was most 
severe at the superior right atrial location (28 ms [IQR, 21–40.5], 
P<0.001). CB indicates conduction block; and CT, conduction 
time.
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more pronounced at the endocardium than the epi-
cardium, particularly at the superior intercaval region. 
Length of these CB lines was longer in patients with 
presence of cardiovascular risk factors. A significant 
degree of EEA is already present during SR, up to 
61 ms in the thin inferior RA and up to 84 ms in the 
thick superior RA, and is also associated with the 
presence of cardiovascular risk factors. Significant 
more conduction disorders and EEA are present in 
patients with persistent AF compared with patients 
without history of AF.
Superior Intercaval Region: A Predilection 
Site for Conduction Disorders
It is generally assumed that the complex architec-
ture and anatomy of the RA plays an important role 
in atrial conduction and arrhythmogenesis. In line 
with previous endo- and/or epicardial mapping stud-
ies, conduction disorders occurred more frequently 
at the superior intercaval region compared with the 
rest of the RA.4,12,13 However, our study was the first 
to simultaneously measure conduction disorders in 
both layers demonstrating that conduction disorders 
occur more frequently at the endocardium than at 
the epicardium. Heterogeneity of the RA endocar-
dial architecture with discontinuous pectinate mus-
cles transversally originating from the terminal crest 
may favor this non-uniform spread of activation.14,15 
In contrast to the endocardium, the epicardial layer 
is more a continuum of cardiomyocytes which may 
favor smooth atrial conduction. These morphological 
differences between both layers result in variability in 
atrial wall thickness and muscle fiber orientation. It 
is reasonable to assume that differences in conduc-
tion disorders between the endo- and epicardium 
are more likely to occur in thicker parts of the atria 
containing more diversity in fiber orientation.
The terminal crest is an embryological demarca-
tion where the sinus venosus merged with the prim-
itive trabeculated RA, possibly also explaining higher 
susceptibility for conduction disorders in the superior 
RA.16 Anatomical features (eg, sinus node cells, ves-
sels, or epicardial fat) of the superior intercaval region 
interrupting the smooth muscular structure may also 
impair atrial conduction resulting in a higher incidence 
of conduction disorders at this specific site.17–19
Endo-Epicardial Asynchrony
The concept of EEA stems from the early 90s, when 
Schuessler et al. performed simultaneous endo-
epicardial mapping of isolated canine atria and 
demonstrated an increase of EEA during atrial tach-
yarrhythmias compared with SR.1 EEA particularly oc-
curred at the superior, relatively thick RA. Eckstein et 
al. performed simultaneous endo-epicardial mapping 
of the left atrium (LA) in goats during SR and acute AF, 
after 3 weeks and after 6 months of AF.2 Almost no 
EEA was observed during SR, but it did increase hand 
in hand with AF duration and occurred up to 50 ms. 
EEA occurred more often at thicker parts of the LA. 
The occurrence of EEA in especially thick parts of the 
atria and the association with AF persistence corre-
spond with our findings and also with prior mapping 
studies examining the RA.3,6 The endo- and epicar-
dium of relative thin parts of the atria, for example in 
between 2 pectinate muscles, are more likely to be 
activated simultaneously. However, as an inevitable ef-
fect of intraoperative in vivo mapping, we were unable 
to correlate degree of EEA with the exact thickness of 
the atrial wall.
Figure 5. Prevalence and degree of endo-epicardial asynchrony.
Left panel: Relative distribution of all endo-epicardial delays (n=161 650) of all local mapping sites, ranked 
according to degree of endo-epicardial delay; 5% of all measurements were above the cut-off value of 
15 ms. Right panel: The pie chart shows the percentage of all locations with endo-epicardial asynchrony 
in the entire study population. EEA indicates endo-epicardial asynchrony.
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Our study clearly demonstrates that even during 
SR, EEA may occur to a significant degree. Therefore, 
it can be concluded that EEA is not an epiphenom-
ena which is related to rapid activation during AF 
only. However, in accordance with mapping stud-
ies showing an increase of EEA during induced AF, 
rapid activation during AF may enhance EEA. The 
present study also demonstrates that EEA may even 
occur in patients without history of AF. These findings 
imply that EEA during SR may be a “physiological” 
phenomena which may aggravate by AF. Recently, 
our research group extended these observations to 
humans and provided the first evidence of EEA for 
both, the RA and LA.3,20 Simultaneous endo-epicar-
dial mapping of the human LA during SR revealed 
occurrence of EEA up to 44 ms in the patient with the 
longest history of AF.20 Hence, EEA can occur any-
where in both atria. This is in line with observations 
in prior epicardial mapping studies demonstrating 
that focal breakthrough waves, which may arise due 
EEA, occurred throughout both atria without any pre-
dilection sites.21 During AF, we observed that focal 
breakthrough waves occurred more often in patients 
with persistent AF compared with acute AF (respec-
tively, median 0.46 per cycle per cm2 versus 0.12, 
P<0.0001).6
From an anatomical perspective, asynchronous 
activation of the endo- and epicardium is more likely 
to occur in thicker parts of the atria, which is in line 
with results of the present study and previous data.1,2,4 
However, as already suggested by Schuessler et al., 
thin parts of the atria are more susceptible to un-
dergo remodeling under pathological circumstances 
such as pressure/volume overload and cardiovascu-
lar risk factors (hypertension, diabetes mellitus, and 
hypercholesterolemia) affecting the microvasculature 
and hence function cardiomyocytes.1 The present 
study demonstrates that a considerable degree of 
EEA up to 61 ms is also present in the thinner RA 
wall (inferior mapping location). Eckstein et al. ob-
served, with persistence of AF (acute AF to 6 months 
of AF), a decrease in LA wall thickness and increase 
in EEA.2 These findings implicate that the absolute 
thickness of the atrial wall together with the degree of 
electrical and structural remodeling are important for 
the occurrence of EEA. Our study provides the first 
evidence for enhancement of EEA by cardiovascular 
risk factors.
The fact that EEA increases from induced to per-
sistent forms of AF substantiates that EEA is important 
for the persistence of AF. The increase in dissociation 
between both layers may result in fragmentation of 
fibrillation waves which stabilizes the fibrillatory pro-
cess because as soon as fibrillation waves die out, 
they can be “replaced” by fibrillation waves from the 
opposite layer and vice versa.3,6
Effect of AF History on Conduction 
Disorders and Endo-Epicardial 
Asynchrony
Previous mapping studies demonstrated that inci-
dence of conduction disorders, breakthrough waves, 
and EEA increase hand in hand with duration of AF.2,3,6 
These AF-induced electropathological alterations in-
crease the complexity of the activation patterns and 
provide a substrate for transmural propagation.22–25 
Electropathological alterations go together with struc-
tural remodeling, such as interstitial fibrosis and re-
modeling in gap junctions.2,26–29 It is most likely that 
remodeling takes not only place in the endo- or epi-
cardium but also transmurally. It can therefore be as-
sumed that these structural changes in the atrial wall 
of patients also disrupt transmural conduction during 
SR. To date, this has only been demonstrated during 
AF, however this study provides the first evidence of 
increased incidence of conduction disorders and EEA 
in patients with persistent AF already during SR.
Limitations
An inevitable effect of intraoperative in vivo mapping in 
humans, is that the underlying anatomy such as vari-
ability in atrial wall thickness and the degree of trabec-
ulation cannot be retrieved. Therefore, we were unable 
to correlate the exact underlying anatomy with the 
mapping data. Simultaneous endo-epicardial map-
ping was only performed of the RA in patients under-
going open heart surgery, thereby precluding the LA. 
However, we recently provided in a pilot study the first 
proof of EEA in the human LA.20 Simultaneous endo-
epicardial mapping of the RA and LA is needed as well 
to gain further insights in the exact role of EEA in the ar-
rhythmogenic substrate of AF. Obtaining SR in patients 
with (longstanding) persistent AF is challenging and in 
most cases not successful. This yielded a limited num-
ber of SR recordings from patients with a history of 
(longstanding) persistent AF. Echocardiographic data 
of sufficient quality to accurately determine RA volume 
were limited. Therefore, we could not correlate RA vol-
ume with conduction disorders and EEA.
CONCLUSIONS
Conduction disorders and EEA during SR appear to 
be most prevalent at the superior RA. Moreover, con-
duction disorders are more prevalent at the endocar-
dium compared with the epicardium. The presence of 
cardiovascular risk factors was associated with longer 
lengths of CB lines at the inferior and superior RA. A 
significant degree of EEA may already present during 
SR. In patients with cardiovascular risk factors EEA was 
more pronounced. SR recordings of patients with per-
sistent AF show more conduction disorders and EEA 
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compared with SR recordings of patients without a 
history of AF. These findings provide unique insights in 
complex relationship between atrial excitation and ar-
rhythmogenesis which needs to be further unraveled 
during AF to improve (ablative) AF therapy.
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